Scotia Capital Inc. Takes Position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Scotia Capital Inc. bought a new position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 4,123 shares of the company’s stock, valued at approximately $271,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. JPMorgan Chase & Co. increased its stake in iShares U.S. Pharmaceuticals ETF by 2,176.8% during the fourth quarter. JPMorgan Chase & Co. now owns 188,567 shares of the company’s stock worth $12,393,000 after purchasing an additional 180,285 shares during the period. Raymond James Financial Inc. purchased a new stake in iShares U.S. Pharmaceuticals ETF during the 4th quarter worth approximately $4,472,000. Pallas Capital Advisors LLC purchased a new stake in iShares U.S. Pharmaceuticals ETF during the 4th quarter worth approximately $3,829,000. Commonwealth Equity Services LLC lifted its holdings in iShares U.S. Pharmaceuticals ETF by 5.5% during the 4th quarter. Commonwealth Equity Services LLC now owns 40,248 shares of the company’s stock worth $2,645,000 after buying an additional 2,106 shares in the last quarter. Finally, Thrivent Financial for Lutherans boosted its position in iShares U.S. Pharmaceuticals ETF by 4.3% in the 4th quarter. Thrivent Financial for Lutherans now owns 33,916 shares of the company’s stock valued at $2,229,000 after buying an additional 1,407 shares during the period.

iShares U.S. Pharmaceuticals ETF Trading Down 0.3 %

iShares U.S. Pharmaceuticals ETF stock opened at $62.95 on Wednesday. The firm has a market capitalization of $572.85 million, a P/E ratio of 21.53 and a beta of 0.63. iShares U.S. Pharmaceuticals ETF has a twelve month low of $58.97 and a twelve month high of $73.28. The stock’s fifty day simple moving average is $68.88 and its 200-day simple moving average is $68.58.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.